More Than Mako: Stryker Delivers Strong Growth In All Three Businesses
Stryker’s revenues grew 8.1% in 2019, its seventh consecutive year of accelerating organic growth and 40th year of sales growth. All three of the company’s major divisions grew in the high single-digits, led by sales of neurotechnology and spine products.
You may also be interested in...
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
Led by the Mako surgical robot, Stryker’s third-quarter sales exceeded Wall Street analysts’ expectations as it prepares to complete the $4bn acquisition of Wright Medical.
The global market for robotic surgery systems is expected to reach $9.7bn by 2023. With medtech giants Medtronic, Johnson & Johnson and Zimmer Biomet launching robotic platforms in 2020, this market is set for a major shakeup.